Research listings · GLP-1 research listings
Retatrutide research listings: prices and suppliers
Research materials and consumer products belong to different categories. A listing, laboratory report, or research-use label does not establish suitability for personal use.
We have no commercial relationship with suppliers on this page. Offers are sorted by price per mg; commission never changes the order.
Prices observed weekly · How we check prices →
Retatrutide listings
No single-substance listings are tracked for Retatrutide yet.
Research context
From our own records, with the date each was last checked.
- FDA approval
- No approved drug product with this ingredient listed in Drugs@FDA (data updated 2026-11-02)Checked
- 503A / 503B compounding
- Not in any 503A category on FDA's 2026-05-14 listChecked
- Advisory committee (PCAC)
- No PCAC meeting on retatrutide found on FDA's 2022 to 2027 PCAC meeting pages (checked 2026-11-03)Checked
- Rulemaking / enforcement
- No Federal Register document found for retatrutide (search on 2026-11-03)Checked
- Identity
- CAS 2381089-83-2Sequence Y-Aib-QGTFTSDYSI-(alpha-MeLeu)-LDK-K*-AQ-Aib-AFIEYLLEGGPSSGAPPPS-NH2; K* (Lys17) carries an AEEA-gamma-Glu-C20 diacid chainSource record Checked
Identity noteSome suppliers sell it under their own code names (for example GLP-3 RT or AP-RTA-3) and identify the molecule only by LY3437943 or its CAS number. Research listings are not an approved medicine.
How we check prices · Offers are matched to our catalogue by an editor before they appear; a listing is not an endorsement.